Dengue-associated transient muscle dysfunction: Clinical, electromyography and histopathological changes

Infection

Volumn 40, Issue 2, 2012, Pages 125-130

  Misra, U K ^a   Kalita, J ^a   Maurya, P K ^a   Kumar, P ^a   Shankar, S K ^a,b   Mahadevan, A ^a,b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

CK; Dengue; EMG; Muscle involvement; Myopathy; Myositis; Outcome

Indexed keywords

CREATINE KINASE; CREATININE; HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; DENGUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOREFLEXIA; LIVER DYSFUNCTION; MALE; MOTOR COORDINATION; MOTOR UNIT POTENTIAL; MUSCLE BIOPSY; MUSCLE BLEEDING; MUSCLE NECROSIS; MUSCLE REFLEX; MUSCLE STRENGTH; MUSCLE TONE; MUSCLE WEAKNESS; PHAGOCYTOSIS; PRESCHOOL CHILD; SENSATION; THROMBOCYTOPENIA; TREATMENT DURATION;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIOPSY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CREATINE KINASE; DENGUE; ELECTROMYOGRAPHY; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MUSCULAR DISEASES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84863187674     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-011-0203-8     Document Type: Article

References (14)

1. Halstead SB, Suaya JA, Shepard DS. The burden of dengue infection. Lancet. 2007;369:1410-1. (Pubitemid 46635764)
2. Solomon T, Dung NM, Vaughn DW et al. Neurological manifestations of dengue infection. Lancet. 2000;355:1053-9. (Pubitemid 30162808)
3. Cam BV, Fonsmark L, Hue NB et al. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg. 2001;65:848-51. (Pubitemid 34049483)
4. Kalita J, Misra UK, Mahadevan A, et al. Acute pure motor quadriplegia: is it dengue myositis? Electromyogr Clin Neurophysiol. 2005;45:357-61. (Pubitemid 41671544)
5. Misra UK, Kalita J, Syam UK, et al. Neurological manifestations of dengue virus infection. J Neurol Sci. 2006;244:117-22.
6. Malheiros SM, Oliveira AS, Schmidt B, et al. Dengue. Muscle biopsy findings in 15 patients. Arq Neuropsiquiatr. 1993;51: 159-64.
7. Sangle SA, Dasgupta A, Ratnalikar SD, et al. Dengue myositis and myocarditis. Neurol India. 2010;58:598-9.
8. Acharya S, Shukla S, Mahajan SN, et al. Acute dengue myositis with rhabdomyolysis and acute renal failure. Ann Indian Acad Neurol. 2010;13:221-2.
9. Ahmad R, Abdul Latiff AK, Abdul Razak S. Myalgia Cruris Epidemica: an unusual presentation of dengue fever. Southeast Asian J Trop Med Public Health. 2007;38:1084-7.
10. Finsterer J, Kongchan K. Severe, persisting, steroid-responsive dengue myositis. J Clin Virol. 2006;35:426-8. (Pubitemid 43324840)
11. Beauvais P, Quinet B, Richardet JM. Dengue. Apropos of 2 cases. Arch Fr Pediatr. 1993;50:905-7.
12. Zaki SA, Shanbag P. Clinical manifestations of dengue and leptospirosis in children in Mumbai: an observational study. Infection. 2010;38(4):285-91.
13. Warke RV, Becerra A, Zawadzka A, et al. Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells. J Gen Virol. 2008;89:1605-15.
14. Chaturvedi UC, Tandon P, Mathur A, et al. Host defence mechanisms against dengue virus infection of mice. J Gen Virol. 1978;39:293-302. (Pubitemid 8327007)